Drugs / Shigella flexneri 2a whole cell (Sf2aWC) vaccine
Shigella flexneri 2a whole cell (Sf2aWC) vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03038243 | Aug 2017 → Dec 2018 | shigellosis | PATH | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Shigella flexneri 2a whole cell (Sf2aWC) vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03038243 ↗ |
| Modality | Vaccine | “inactivated whole cell Shigella flexneri 2a killed vaccine (Sf2aWC)” NCT03038243 ↗ |
| Route | Oral | “2.25 x 10\^11 Sf2WC cells administered orally on Days 0, 28, and 56” NCT03038243 ↗ |